Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Combinations of ABBV- 368 plus Tilsotolimod in Subjects with Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma study (Abbvie M19-894)
Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Combinations of ABBV- 368 plus Tilsotolimod in Subjects with Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma study (Abbvie M19-894)
Trial Category:
Head and Neck
Phase
I
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE